miR-369-3p Serves as Prognostic Factor and Regulates Cancer Progression of Hepatocellular Carcinoma

References

• Zhang K , SongP , GaoJ , LiG , ZhaoX , ZhangS. Perspectives on a combined test of multi serum biomarkers in China: towards screening for and diagnosing hepatocellular carcinoma at an earlier stage. Drug Discov. Ther.8(3), 102–109 (2014).
   PubMedGoogle Scholar
• Zhu ZX , HuangJW , LiaoMH , ZengY. Treatment strategy for hepatocellular carcinoma in China: radiofrequency ablation versus liver resection. Jpn J. Clin. Oncol.46(12), 1075–1080 (2016).
   PubMed Web of Science ®Google Scholar
• Forner A , LlovetJM , BruixJ. Hepatocellular carcinoma. Lancet379(9822), 1245–1255 (2012).
   PubMed Web of Science ®Google Scholar
• Rongrui L , NaH , ZongfangL , FanpuJ , ShiwenJ. Epigenetic mechanism involved in the HBV/HCV-related hepatocellular carcinoma tumorigenesis. Curr. Pharm. Des.20(11), 1715–1725 (2014).
   PubMed Web of Science ®Google Scholar
• Takayama T , MakuuchiM , KojiroMet al. Early hepatocellular carcinoma: pathology, imaging, and therapy. Ann. Surg. Oncol.15(4), 972–978 (2008).
   PubMed Web of Science ®Google Scholar
• Allemani C , MatsudaT , DiCarlo Vet al. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet391(10125), 1023–1075 (2018).
   PubMed Web of Science ®Google Scholar
• Ameres SL , ZamorePD. Diversifying microRNA sequence and function. Nat. Rev. Mol. Cell Biol.14(8), 475–488 (2013).
   PubMed Web of Science ®Google Scholar
• Liu Y , ChengZ , PanF , YanW. MicroRNA-373 promotes growth and cellular invasion in osteosarcoma cells by activation of the PI3K/AKT-Rac1-JNK pathway: the potential role in spinal osteosarcoma. Oncol. Res.25(6), 989–999 (2017).
   PubMed Web of Science ®Google Scholar
• Huang D , WangF , WuW , LianC , LiuE. MicroRNA-429 inhibits cancer cell proliferation and migration by targeting the AKT1 in melanoma. Cancer Biomark.26(1), 63–68 (2019).
   PubMed Web of Science ®Google Scholar
• Youness RA , El-TayebiHM , AssalRA , HosnyK , EsmatG , AbdelazizAI. MicroRNA-486-5p enhances hepatocellular carcinoma tumor suppression through repression of IGF-1R and its downstream mTOR, STAT3 and c-Myc. Oncol. Lett.12(4), 2567–2573 (2016).
   PubMed Web of Science ®Google Scholar
• Yoon JS , KimG , LeeYRet al. Clinical significance of microRNA-21 expression in disease progression of patients with hepatocellular carcinoma. Biomark. Med.12(10), 1105–1114 (2018).
   PubMed Web of Science ®Google Scholar
• Condrat CE , ThompsonDC , BarbuMGet al. miRNAs as biomarkers in disease: latest findings regarding their role in diagnosis and prognosis. Cells9(2), 276 (2020).
   PubMed Web of Science ®Google Scholar
• Pan YJ , WanJ , WangCB. MiR-326: promising biomarker for cancer. Cancer Manag. Res.11, 10411–10418 (2019).
   PubMed Web of Science ®Google Scholar
• Wang X , GaoJ , ZhouB , XieJ , ZhouG , ChenY. Identification of prognostic markers for hepatocellular carcinoma based on miRNA expression profiles. Life Sci.232, 116596 (2019).
   PubMed Web of Science ®Google Scholar
• Qadir MI , RizviSZ. miRNA in hepatocellular carcinoma: pathogenesis and therapeutic approaches. Crit. Rev. Eukaryot. Gene Expr.27(4), 355–361 (2017).
   PubMed Web of Science ®Google Scholar
• Xu X , TaoY , NiuYet al. miR-125a-5p inhibits tumorigenesis in hepatocellular carcinoma. Aging11(18), 7639–7662 (2019).
   PubMedGoogle Scholar
• Galleggiante V , DeSantis S , LisoMet al. Quercetin-induced miR-369-3p suppresses chronic inflammatory response targeting C/EBP-beta. Mol. Nutr. Food Res.63(19), e1801390 (2019).
   PubMed Web of Science ®Google Scholar
• Guo S , ZhangW , WeiCet al. Serum and skin levels of miR-369-3p in patients with psoriasis and their correlation with disease severity. Eur. J. Dermatol.23(5), 608–613 (2013).
   PubMed Web of Science ®Google Scholar
• Pan W , YuH , ZhengBet al. Upregulation of miR-369-3p suppresses cell migration and proliferation by targeting SOX4 in Hirschsprung’s disease. J. Pediatr. Surg.52(8), 1363–1370 (2017).
   PubMed Web of Science ®Google Scholar
• Li P , DongM , WangZ. Downregulation of TSPAN13 by miR-369-3p inhibits cell proliferation in papillary thyroid cancer (PTC). Bosn. J. Basic Med. Sci.19(2), 146–154 (2019).
   PubMed Web of Science ®Google Scholar
• Zheng J , SadotE , VigidalJAet al. Characterization of hepatocellular adenoma and carcinoma using microRNA profiling and targeted gene sequencing. PLoS ONE13(7), e0200776 (2018).
   PubMed Web of Science ®Google Scholar
• Hur W , RhimH , JungCKet al. SOX4 overexpression regulates the p53-mediated apoptosis in hepatocellular carcinoma: clinical implication and functional analysis in vitro. Carcinogenesis31(7), 1298–1307 (2010).
   PubMed Web of Science ®Google Scholar
• Wang X , ZhangY , FengTet al. Fluid shear stress promotes autophagy in hepatocellular carcinoma cells. Int. J. Biol. Sci.14(10), 1277–1290 (2018).
   PubMed Web of Science ®Google Scholar
• Wei D , YuG , ZhaoY. MicroRNA-30a-3p inhibits the progression of lung cancer via the PI3K/AKT by targeting DNA methyltransferase 3a. OncoTargets Ther.12, 7015–7024 (2019).
   PubMedGoogle Scholar
• Nong K , ZhangD , ChenCet al. MicroRNA-519 inhibits hypoxia-induced tumorigenesis of pancreatic cancer by regulating immune checkpoint PD-L1. Oncol. Lett.19(2), 1427–1433 (2020).
   PubMed Web of Science ®Google Scholar
• Yoon JS , KimG , LeeYRet al. Clinical significance of microRNA-21 expression in disease progression of patients with hepatocellular carcinoma. Biomark. Med.12(10), 1105–1114 (2018).
   PubMed Web of Science ®Google Scholar
• Zeng B , LiY , FengYet al. Downregulated miR-1247-5p associates with poor prognosis and facilitates tumor cell growth via DVL1/Wnt/beta-catenin signaling in breast cancer. Biochem. Biophys. Res. Commun.505(1), 302–308 (2018).
   PubMed Web of Science ®Google Scholar
• Roy S , TrautweinC , LueddeT , RoderburgC. A general overview on non-coding RNA-based diagnostic and therapeutic approaches for liver diseases. Front. Pharmacol.9, 805 (2018).
   PubMed Web of Science ®Google Scholar
• Roy S , HooiveldGJ , SeehawerMet al. microRNA 193a-5p regulates levels of nucleolar- and spindle-associated protein 1 to suppress hepatocarcinogenesis. Gastroenterology155(6), 1951–1966 (2018).
   PubMed Web of Science ®Google Scholar
• Dang S , ZhouJ , WangZ , WangK , DaiS , HeS. MiR-299-3p functions as a tumor suppressor via targeting sirtuin 5 in hepatocellular carcinoma. Biomed. Pharmacother.106, 966–975 (2018).
   PubMed Web of Science ®Google Scholar
• Ni M , ZhaoY , ZhangWJet al. microRNA-802 accelerates hepatocellular carcinoma growth by targeting RUNX3. J. Cell. Physiol.235(10), 7128–7135 (2020).
   PubMed Web of Science ®Google Scholar
• He J , XiaoB , LiX , HeY , LiL , SunZ. MiR-486-5p suppresses proliferation and migration of hepatocellular carcinoma cells through downregulation of the E3 ubiquitin ligase CBL. BioMed Res. Int.2019, 2732057 (2019).
   PubMed Web of Science ®Google Scholar
• Petrovic N , ErgunS. miRNAs as potential treatment targets and treatment options in cancer. Mol. Diagn. Ther.22(2), 157–168 (2018).
   PubMed Web of Science ®Google Scholar
• Rocco GD , BaldariS , ToiettaG. Exosomes and other extracellular vesicles-mediated microRNA delivery for cancer therapy. Transl. Cancer Res.6(8), S1321–S1330 (2017).
   Google Scholar
• Thayanithy V , SarverAL , KarthaRVet al. Perturbation of 14q32 miRNAs-cMYC gene network in osteosarcoma. Bone50(1), 171–181 (2012).
   PubMed Web of Science ®Google Scholar
• Dong L , ZhangZ , XuJet al. Consistency analysis of microRNA-arm expression reveals microRNA-369-5p/3p as tumor suppressors in gastric cancer. Mol. Oncol.13(7), 1605–1620 (2019).
   PubMed Web of Science ®Google Scholar
• Xu Q , LiuK. MiR-369-3p inhibits tumorigenesis of hepatocellular carcinoma by binding to PAX6. J. Biol. Regul. Homeost. Agents34(3), 917–926 (2020).
   PubMed Web of Science ®Google Scholar
• Fernández-Ramos D , Fernández-TussyP , Lopitz-OtsoaFet al. MiR-873-5p acts as an epigenetic regulator in early stages of liver fibrosis and cirrhosis. Cell Death Dis.9(10), 958 (2018).
   PubMedGoogle Scholar
• Avila MA , BerasainC , IruzibietaPet al. Serum miR-21 and miR-26a levels negatively correlate with severity of cirrhosis in patients with chronic hepatitis B. Cell Death Dis.8(1), 86–92 (2019).
   Google Scholar
• Zou Y , YaoS , ChenXet al. LncRNA OIP5-AS1 regulates radioresistance by targeting DYRK1A through miR-369-3p in colorectal cancer cells. Eur. J. Cell Biol.97(5), 369–378 (2018).
   PubMed Web of Science ®Google Scholar
• Hao GJ , DingYH , WenHet al. Attenuation of deregulated miR-369-3p expression sensitizes non-small-cell lung cancer cells to cisplatin via modulation of the nucleotide sugar transporter SLC35F5. Biochem. Biophys. Res. Commun.488(3), 501–508 (2017).
   PubMed Web of Science ®Google Scholar
• Liu P , MaC , WuQet al. MiR-369-3p participates in endometrioid adenocarcinoma via the regulation of autophagy. Cancer Cell Int.19, 178 (2019).
   PubMed Web of Science ®Google Scholar
• Chang J , GaoF , ChuH , LouL , WangH , ChenY. miR-363-3p inhibits migration, invasion, and epithelial-mesenchymal transition by targeting NEDD9 and SOX4 in non-small-cell lung cancer. J. Cell. Physiol.235(2), 1808–1820 (2020).
   PubMed Web of Science ®Google Scholar
• Hanieh H , AhmedEA , VishnubalajiR , AlajezNM. SOX4: epigenetic regulation and role in tumorigenesis. Semin. Cancer Biol.67(Pt 1), 91–104 (2019).
   PubMedGoogle Scholar
• Jafarnejad SM , ArdekaniGS , GhaffariM , LiG. Pleiotropic function of SRY-related HMG box transcription factor 4 in regulation of tumorigenesis. Cell. Mol. Life Sci.70(15), 2677–2696 (2013).
   PubMed Web of Science ®Google Scholar
• Zheng JH , JianZX , JinHS , ChenSC , WangGY. [Expression of SOX4 gene and early recurrence of hepatocellular carcinoma: their relationship and the clinical significance]. Nan Fang Yi Ke Da Xue Xue Bao30(4), 818–819 (2010).
   PubMedGoogle Scholar
• Zhang J , XiaoC , FengZet al. SOX4 promotes the growth and metastasis of breast cancer. Cancer Cell Int.20, 468 (2020).
   PubMed Web of Science ®Google Scholar
• Wang B , LiY , TanF , XiaoZ. Increased expression of SOX4 is associated with colorectal cancer progression. Cancer Cell Int.37(7), 9131–9137 (2016).
   Google Scholar
• Moran JD , KimHH , LiZ , MorenoCS. SOX4 regulates invasion of bladder cancer cells via repression of WNT5a. Int. J. Oncol.55(2), 359–370 (2019).
   PubMed Web of Science ®Google Scholar
• Tsai CN , YuSC , LeeCWet al. SOX4 activates CXCL12 in hepatocellular carcinoma cells to modulate endothelial cell migration and angiogenesis in vivo. Oncogene39(24), 4695–4710 (2020).
   PubMed Web of Science ®Google Scholar